LivaNova PLC (LIVN)

Pretax margin

		Dec 31, 2023	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021	Jun 30, 2021	Mar 31, 2021	Dec 31, 2020	Sep 30, 2020	Jun 30, 2020	Mar 31, 2020	Dec 31, 2019	Sep 30, 2019	Jun 30, 2019	Mar 31, 2019
Earnings before tax but after interest (EBT) (ttm)	US$ in thousands	-81,330	19,348	-84,691	-70,984	-75,195	-83,899	-19,435	-90,973	-124,620	-421,872	-399,091	-369,642	-349,779	-200,361	-160,092	-172,341	-185,550	-315,770	-347,072	-297,657
Revenue (ttm)	US$ in thousands	1,093,987	1,057,777	1,026,749	989,010	971,142	983,022	925,125	933,289	932,621	932,112	974,900	901,723	907,604	925,639	964,065	1,062,089	1,073,680	1,083,073	1,091,319	1,105,702
Pretax margin		-7.43%	1.83%	-8.25%	-7.18%	-7.74%	-8.53%	-2.10%	-9.75%	-13.36%	-45.26%	-40.94%	-40.99%	-38.54%	-21.65%	-16.61%	-16.23%	-17.28%	-29.16%	-31.80%	-26.92%

December 31, 2023 calculation

Pretax margin = EBT (ttm) ÷ Revenue (ttm)
= $-81,330K ÷ $1,093,987K
= -7.43%

The pretax margin of LivaNova PLC has shown fluctuating trends over the past eight quarters, ranging from a low of -8.97% in Q1 2022 to a high of 1.73% in Q3 2023. The company experienced negative pretax margins in five out of the eight quarters, indicating that its profitability before taxes has been challenged. The most recent data in Q4 2023 shows a pretax margin of -7.05%, which suggests that the company still faces profitability issues. Overall, LivaNova PLC needs to focus on improving its operational efficiency and cost management to enhance its profitability in the future.

Peer comparison

Dec 31, 2023

Company name

Symbol

Pretax margin

LivaNova PLC

LIVN

-7.43%

BioLife Solutions Inc